$1.20
0.01[0.84%]
At close: Apr 26
$1.20
0[0.00%]
After Hours: 4:20PM EDT
Aclaris Therapeutics
(NASDAQ:ACRS)Aclaris Therapeutics Stock (NASDAQ:ACRS), Insider Trading Activity
Aclaris Therapeutics: Insider buying and selling updated today.
Insider Shares Owned
2.876M
Insider Percentage Owned
4.05%
Institutional Shares Held
17.632M
Institutional Percentage Held
24.9%
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 05, 2024 | William Kenneth Andrew Powell | DIRECTOR | 14.5K | $1.24 | $17.95K | BUY | 100.95% | 28.863K | Mar 01 - Mar 04 | View |
| Oct 25, 2023 | Joseph Monahan | CHIEF SCIENTIFIC OFFICER | -6K | $5.08 | -$30.46K | SELL | -4.41% | 129.917K | Oct 23 | View |
| Sep 07, 2023 | Kevin Balthaser | CHIEF FINANCIAL OFFICER | 9.49K | $7.90 | $74.97K | BUY | 158.93% | 15.461K | Sep 06 | View |
| Aug 28, 2023 | James Loerop | CHIEF BUSINESS OFFICER | 14.705K | $6.80 | $99.96K | BUY | 210.58% | 21.688K | Aug 28 | View |
| Aug 22, 2023 | Joseph Monahan | CHIEF SCIENTIFIC OFFICER | -6K | $7.32 | -$43.89K | SELL | -4.23% | 135.917K | Aug 21 | View |
| Jun 22, 2023 | Joseph Monahan | CHIEF SCIENTIFIC OFFICER | -6K | $10.28 | -$61.66K | SELL | -4.06% | 141.917K | Jun 20 | View |
| Mar 17, 2023 | Douglas Manion | PRES AND CEO | 6.3K | $7.86 | $49.53K | BUY | 96.92% | 12.8K | Mar 17 | View |
| Mar 09, 2023 | Douglas Manion | PRES AND CEO | 6.5K | $7.74 | $50.28K | BUY | ∞ | 6.5K | Mar 09 | View |
| Mar 03, 2023 | Neal Walker | DIRECTOR | 97.439K | $12.50 | -$740.66K | SELL-OPTIONS | 8.29% | 1.273202M | Mar 01 - Mar 03 | View |
| Mar 03, 2023 | Joseph Monahan | CHIEF SCIENTIFIC OFFICER | 56.338K | $12.51 | -$385.64K | SELL-OPTIONS | 61.52% | 147.917K | Mar 01 - Mar 03 | View |
| Mar 03, 2023 | Kevin Balthaser | CHIEF FINANCIAL OFFICER | 4.556K | $12.45 | -$23.58K | SELL-OPTIONS | 650.86% | 5.256K | Mar 01 - Mar 03 | View |
| Feb 17, 2023 | Joseph Monahan | CHIEF SCIENTIFIC OFFICER | -5K | $13.06 | -$65.31K | SELL | -5.18% | 91.579K | Feb 15 | View |
| Feb 10, 2023 | James Loerop | CHIEF BUSINESS OFFICER | -4.267K | $13.89 | -$59.27K | SELL | -37.93% | 6.983K | Feb 08 | View |
| Feb 03, 2023 | Neal Walker | DIRECTOR | -30K | $16.66 | -$499.92K | SELL | -2.49% | 1.175763M | Feb 01 - Feb 02 | View |
| Jan 04, 2023 | Neal Walker | DIRECTOR | -40K | $15.11 | -$604.56K | SELL | -3.21% | 1.205763M | Jan 03 - Jan 04 | View |
| Dec 16, 2022 | Joseph Monahan | CHIEF SCIENTIFIC OFFICER | -5K | $15.88 | -$79.41K | SELL | -4.92% | 96.579K | Dec 15 | View |
| Nov 14, 2022 | ANDREW SCHIFF | DIRECTOR | -53.926K | $17.05 | -$919.59K | SELL | -11.04% | 434.455K | Nov 10 - Nov 14 | View |
| Oct 26, 2022 | ANDREW SCHIFF | DIRECTOR | -41.174K | $17.01 | -$700.36K | SELL | -7.78% | 488.381K | Oct 24 - Oct 26 | View |
| Oct 19, 2022 | ANDREW SCHIFF | DIRECTOR | -52.037K | $16.57 | -$862.11K | SELL | -8.95% | 529.555K | Oct 17 - Oct 18 | View |
FAQ
Is Insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.